Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.35 |
| ▸ | OTC | P00480 | 1/20 | 0.35 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2510162 | 0.80 | — | — | |
| SCHEMBL11474902 | 0.80 | GRM4 (0.42) | GRM4KDM4EMMP2THRBMAPK1 | |
| SCHEMBL11746955 | 0.78 | FDPS (0.43) | GRM4KDM4EMMP2THRBMAPK1 | |
| SCHEMBL970448 | 0.75 | — | — | |
| SCHEMBL8337169 | 0.75 | FDPS (0.41) | GRM4KDM4EMMP2THRBMAPK1 | |
| SCHEMBL10881796 | 0.73 | — | — | |
| SCHEMBL6659016 | 0.72 | KDM4E (0.44) | GRM4KDM4EMMP2THRBMAPK1 | |
| SCHEMBL8754504 | 0.71 | FDPS (0.41) | GRM4FDPSLAP3 | |
| SCHEMBL1378555 | 0.71 | FDPS (0.41) | GRM4FDPSLAP3 | |
| SCHEMBL11785300 | 0.71 | FDPS (0.41) | GRM4FDPSTYMSLMNABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9453117-B2 | Triazine compounds containing phosphorous as flame retardants | J.M. HUBER CORPORATION (US) | 2016-09-27 | — | — | US | disclosed |
| US-20160053088-A1 | Triazine Compounds Containing Phosphorous as Flame Retardants | HUBER CORP J M (US) | 2016-02-25 | — | — | US | disclosed |
| US-9200122-B2 | Triazine compounds containing phosphorous as flame retardants | J. M. HUBER CORPORATION (US) | 2015-12-01 | — | — | US | disclosed |
| US-20140364570-A1 | TRIAZINE COMPOUNDS CONTAINING PHOSPHOROUS AS FLAME RETARDANTS | CATENA ADDITIVES GMBH & CO. KG | 2014-12-11 | — | — | US | disclosed |
| US-8754154-B2 | Triazine compounds containing phosphorous as flame retardants | CATENA ADDITIVES GMBH & CO. KG (DE) | 2014-06-17 | — | — | US | disclosed |
| EP-1523474-B2 | CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS | SOLVAY SPECIALTY POLYMERS IT (IT) | 2012-12-19 | — | — | EP | disclosed |
| US-20110245383-A1 | TRIAZINE COMPOUNDS CONTAINING PHOSPHOROUS AS FLAME RETARDANTS | J.M. HUBER CORPORATION | 2011-10-06 | — | — | US | disclosed |
| US-7943657-B2 | bleach or a disinfectant composition comprising an imido-alkanpercarboxylic acid | SOLVAY SOLEXIS S.P.A. (IT) | 2011-05-17 | — | — | US | disclosed |
| EP-1523474-B1 | CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS | SOLVAY SOLEXIS SPA (IT) | 2009-07-01 | — | — | EP | disclosed |
| US-7468387-B2 | Crystalline forms of imidoalkanpercarboxylic acids | SOLVAY SOLEXIS S.P.A. (IT) | 2008-12-23 | — | — | US | disclosed |
| US-6083403-A | METAL SURFACES | NALCO CHEMICAL COMPANY (US) | 2000-07-04 | — | — | US | disclosed |
| US-5703245-A | HEATING SUSPENSION OF IMIDO ACIDS TO MELTING, SEPARATION OF ORGANIC PHASE | AUSIMONT, S.P.A. (IT) | 1997-12-30 | — | — | US | disclosed |
| EP-0780374-A1 | Process for reducing water and polar impurities in imido-alkanpercarboxylic acids | AUSIMONT S.p.A. (IT) | 1997-06-25 | — | — | EP | disclosed |
| WO-1992020620-A1 | METHOD FOR CATALYTIC PRODUCTION OF HYDROGEN PEROXIDE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-11-26 | — | — | WO | disclosed |
| US-5135731-A | Method for catalytic production of hydrogen peroxide | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-08-04 | — | — | US | disclosed |
| US-4248633-A | Universal copper-plating solution | U.S. PHILIPS CORPORATION (US) | 1981-02-03 | — | — | US | disclosed |
| US-4164574-A | Use of polyquaternary ammonium methylene phosphonates as microbiocides | PETROLITE CORPORATION (US) | 1979-08-14 | — | — | US | disclosed |
| US-4084950-A | SCALE INHIBITION, CHELATION | PETROLITE CORPORATION (US) | 1978-04-18 | — | — | US | disclosed |
| US-4075243-A | ANTISCALING, CHELATION, BACTERICIDES | PETROLITE CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
| US-3966630-A | Use of polyquaternary ammonium methylene phosphonates in chelating or scale inhibition | PETROLITE CORPORATION (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160053088-A1 | Triazine Compounds Containing Phosphorous as Flame Retardants | PFAS, TAF11, PUF60 | GRM4 1290/4885KDM4E 1905/4885MMP2 4377/4885 |
| US-20110245383-A1 | TRIAZINE COMPOUNDS CONTAINING PHOSPHOROUS AS FLAME RETARDANTS | AP2A2, P2RX2, AP2M1 | GRM4 461/4885KDM4E 4381/4885MMP2 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.